During mammalian lung development, the morphological transition from respiratory tree branching morphogenesis to a predominantly saccular architecture, capable of air-breathing at birth, is dependent on physical forces as well as molecular signaling by a range of transcription factors including the cAMP response element binding protein 1 (Creb1). Creb1 −/− mutant mice exhibit complete neonatal lethality consistent with a lack of lung maturation beyond the branching phase. To further define its role in the developing mouse lung, we deleted Creb1 separately in the respiratory epithelium and mesenchyme. Surprisingly, we found no evidence of a morphological lung defect nor compromised neonatal survival in either conditional Creb1 mutant. Interestingly however, loss of mesenchymal Creb1 on a genetic background lacking the related Crem protein showed normal lung development but poor neonatal survival. To investigate the underlying requirement for Creb1 for normal lung development, Creb1 −/− mice were re-examined for defects in both respiratory muscles and glucocorticoid hormone signaling, which are also required for late stage lung maturation. However, these systems appeared normal in Creb1 −/− mice. Together our results suggest that the requirement of Creb1 for normal mammalian lung morphogenesis is not dependent upon its expression in lung epithelium or mesenchyme, nor its role in musculoskeletal development.
. The role of Creb1/Atf family members in developmental (and other) processes has, in part, been revealed by gene targeted mutations in mice. Inactivation of Atf1 or Crem does not appear to affect gross development, although Crem −/− males become sterile due to impaired spermatogenesis 6, 7 . Mice lacking Creb1 isoforms α and β (Creb1 αΔ ) are found at a reduced Mendelian frequency indicating a developmental disadvantage, but are otherwise viable and healthy 8 . However, complete inactivation of Creb1 function via loss of isoforms α , β and Δ (Creb1 −/− ) suffer multiple defects including reduced birth weight, brain deformities, impaired T cell development and cessation of lung sacculation causing neonatal lethality 9 . Our investigation of a similar Creb1 mutant revealed an almost identical whole body and respiratory phenotype, and further showed that Creb1 −/− lungs had not developed beyond the pseudoglandular stage 10 . Importantly, analysis of this latter mutant demonstrated that complete loss of Creb1 could not be rescued by the activities of other Creb/Atf members, a compensatory mechanism described in studies using both compound Creb/Atf1 knockouts 7 as well as conditional Creb1 mutants on a genetic background lacking either Crem or Atf1 11, 12 .
Although the phenotype of total Creb1-mutants indicates a requirement for Creb1 signaling during lung saccular stage development, the underlying molecular mechanisms remain unclear. Localization of transcriptionally active Creb1 in the fetal mouse lung using Ser133 phosphorylated Creb1 (pCreb1) immunostaining strongly suggests a role in the distal epithelium 10, 13 . This is also consistent with the known stimulatory effect of cAMP on surfactant protein family gene transcription (Reviewed in 14 ) . Furthermore, total Creb1-mutants display a severe lack of AEC, and to a lesser extent, proximal epithelial cell marker expression while mesenchymal-derived vasculature and smooth muscle development appear unaffected 10 . Despite this, persistent Creb1 and pCreb1 expression in mesenchymal cell subsets, particularly during the saccular phase 10 , also suggest a function for Creb1 in the developing lung mesenchyme.
In this study, we have investigated the functional role of Creb1 in the developing respiratory epithelium and mesenchyme by conditional Creb1 deletion within these germ layers. We initially explored the importance of Creb1 for neonatal survival, morphological lung development and also epithelial cell differentiation during the saccular phase. Surprisingly, in these analyses we did not observe any requirement for Creb1 in any specific lung germ layer. To test for possible compensation by Creb/Atf members in conditional Creb1 knockout lungs, we assessed relative Crem and Atf1 gene expression levels and also lung morphology in conditional knockouts on a Crem deficient background. Ruling out these effects, we then re-examined total Creb1 −/− fetal mice for defects in extra-pulmonary systems which are known to indirectly influence saccular lung development. Together our results indicate that loss of either respiratory epithelial or mesenchymal Creb1 expression is dispensable for lung development and neonatal survival, and is not compensated for by other Creb/Atf1 members. Lastly, we find that the respiratory phenotype in Creb1 −/− mice is likely not due to deficiencies in either glucocorticoid (GC) signaling or muscular-driven physical forces which are also essential for normal saccular lung development.
Results
Conditional loss of Creb1 in lung epithelium and mesenchyme does not impair survival at birth. We first assessed the impact of lung epithelial Creb1 deletion on neonatal survival. Lung epithelial deletion was achieved using a doxycycline-inducible Cre/LoxP system. In this approach, Creb1 fl/fl mice were bred to SPCrtTA tg/− and TetO-cre tg/− strains to generate triple transgenic pups bearing all three alleles. This allows for Creb1 deletion in the respiratory epithelium due to the restricted expression of reverse tetracycline transactivator (rtTA) from the hSFTPC promoter. The rtTA, together with externally provided doxycycline in rodent food, then drive expression of Cre recombinase via the Tet(O 7 )CMV promoter to completely remove Creb1 expression in the lung epithelium (Fig. 1a) EpKO mice in all analyses. Surprisingly, genotyping analysis of litters at two weeks of age showed no significant deviations from the expected 25% Mendelian frequency in Creb1
EpKO mice (Table 1) . Furthermore, we did not observe any obvious abnormalities in these mice throughout adulthood.
We then investigated the requirement for mesenchymal Creb1 in the developing lung via mesenchymal-specific Creb1 deletion. This was achieved using a Dermo1-cre strain which express Cre recombinase as early as E13.5 within a variety of mesodermal-derived tissues including lung mesenchyme [16] [17] [18] . However, due to the very close proximity of the Creb1 and Dermo1 (Twist2) genes on chromosome 1 (~29 Mb apart), matings between Creb1 fl/+ ;Dermo1 Cre/+ and Creb1 fl/fl mice resulted in a highly unequal frequency of progeny genotypes, (distinct from the knockout phenotype) and was therefore not an appropriate means of assessing survival. Nevertheless, the few Creb1 fl/fl
;Dermo1
Cre/+ mice (hereafter referred to as Creb1
MesKO
) that were produced appeared healthy and were fertile. In addition, when Creb1
MesKO mice were mated with Creb1 fl/fl mice, we found no significant deviations from the expected 50% Creb1
MesKO frequency when litters were genotyped at two weeks of age (Table 2) . We also investigated Creb1 deletion in the endothelium using Tie2-cre mice which express Cre recombinase as early as E7.5 in the vascular endothelium 19 . However, in the two litters analysed (15 pups) we did not observe any loss of survival or other defects in Creb1 fl/fl
;Tie2
Cre/+ mice (hereafter referred to as "Creb1 EndoKO "). Total Creb1 knockout mice were also generated by mating Creb1 fl/fl to CMV-Cre mice, which show Cre activity in all tissues before embryo implantation 20 . Complete neonatal lethality in a separate strain of Creb1 −/− mice (bearing an exon 10 disruption) has previously been shown 9 , and although our Efficacy of respiratory epithelial and mesenchymal Creb1 deletion. To determine the degree of Creb1 deletion in respective lung germ layers, we performed immunohistochemistry for Creb1 at E17.5 where the mesenchymal tissue between developing epithelial buds is clearly defined. In all controls examined, Creb1 expression was highly expressed in all germ layers (Fig. 1b,e) . Respiratory epithelial-specific Creb1 deletion was variable in Creb1
EpKO mice, with some animals showing almost complete loss of Creb1 expression in lung epithelium (as shown in Fig. 1c,d ) while others showed greatly reduced, but incomplete deletion in lung epithelium. The extent of Creb1 deletion in Creb1
EpKO mice appeared particularly variable in the proximal lung epithelium, with distinct clusters of Creb1+ cells often observed in the conducting airway ( Supplementary Fig. S1 ). This was also evident as early as E15.5, although at these earlier stages Creb1+ cells were less frequently observed ( Supplementary  Fig. S1 ). In comparison, the distal lung epithelium showed a much more complete and consistent absence of Creb1 expression in Creb1
EpKO mice ( Fig. 1d and Supplementary Fig. S1 ). In Creb1 MesKO mice, lung mesenchymal Creb1 expression was almost completely abolished, although a few rare interstitial Creb1+ cells were observed (Fig. 1f,g ). We also observed loss of Creb1 in chondrocytes in Creb1
MesKO mice, consistent with the known spatial expression of Dermo1
Cre in several non-respiratory tissues 16 ( Supplementary Fig. S1 ). Efficient Creb1 deletion in endothelial cells was also observed in lungs of Creb1
EndoKO mice ( Supplementary Fig. S1 ). As expected, total loss of Creb1 expression was always observed in the lung of Creb1 fl−/− mice (Fig. 1h ).
The Creb1
−/− respiratory phenotype is not recapitulated by loss of Creb1 in lung epithelium and mesenchyme. Histological analysis was used to investigate potential alterations to lung morphology in E18.5 Creb1
EpKO , Creb1
MesKO and Creb1 EndoKO mice. Unexpectedly, we found no consistent morphological differences in E18.5 Creb1
EpKO lungs when compared to controls (Fig. 2a, 
b). As we had often found variable lung epithelial Creb1 deletion in fetal Creb1
EpKO mice, we looked to see whether the extent of Creb1 deletion correlated to any degree of abnormal lung morphology. However, even in Creb1
EpKO mice with the most complete level of lung epithelial Creb1 deletion we noted no difference in morphology compared with littermate controls. A tissue-to-airspace measurement also revealed no difference in overall cellularity in E17.5 Creb1
EpKO lungs ( Supplementary Fig. S2 ). Similarly, loss of mesenchymal or endothelial Creb1 in Creb1
MesKO and Creb1 EndoKO mice respectively, did not affect lung morphology ( Fig. 2c-e) . Due to the lack of significant pCreb1 expression in lung endothelial cells relative to other mesenchymal lineages and the epithelium 10 , from herein our analysis does not include Creb1
EndoKO mice. Adult lung structure in Creb1 EpKO and Creb1 MesKO mice also appeared similar to controls ( Supplementary Fig. S3 ). In comparison, lungs of E18.5 Creb1 fl−/− mice displayed almost no expansion of airways and retained a morphology similar to that of late pseudoglandular-stage lungs, consistent with previous analysis of the Creb1 −/− respiratory phenotype 10 ( Fig. 2f ). Together these results suggest that Creb1 expression in lung epithelium, mesenchyme or endothelium separately is not required for normal lung development.
Epithelial differentiation is unaffected in Creb1
EpKO and Creb1 MesKO fetal lungs. Although neonatal survival and fetal lung morphology appeared to be unaffected in Creb1 EpKO and Creb1 MesKO mice, we reasoned that abnormalities in lung epithelial cell differentiation may still be present based on our previous findings showing altered levels of proximal and distal epithelial cell markers in Creb1 fl−/− lungs 10 . We therefore used immunohistochemistry to investigate the differentiation of neuroendocrine, ciliated and secretory (Clara) cells in E18.5 Creb1
EpKO and Creb1 MesKO lungs using the proximal lung epithelial cell markers CGRP (also known as Calca), β -tubulin IV and CC10 (also known as Scgb1a1), respectively. However, we did not observe any difference in relative levels or spatial localization of these markers in Creb1
EpKO and Creb1 MesKO lungs (Fig. 3a-f ,i-n). Distal epithelial cell differentiation also appeared unaffected in E18.5 Creb1
EpKO and Creb1 MesKO lungs as shown by immunohistochemistry for the type-II AEC marker, ProSPC (Fig. 3g,h,o,p) . Using qPCR, we also examined gene expression of proximal and distal lung epithelial cell markers in E18.5 Creb1
EpKO and Creb1 MesKO lungs using qPCR. Consistent with our immunostaining results, no prominent alterations in mRNA levels were observed, though a reduction in levels for FoxJ1 (in Creb1
EpKO lungs) and Aqp5 (in Creb1 MesKO lungs) was noted ( Supplementary Fig. S4 ). Loss of respiratory epithelial or mesenchymal Creb1 in fetal lung is not rescued by Crem or Atf1 compensation. To test for possible compensatory up-regulation by the Creb/Atf family members Crem and Atf1, we firstly examined mRNA levels for these factors in E18.5 Creb1
EpKO and Creb1 MesKO lungs using qPCR. We found no changes in Atf1 mRNA levels in Creb1
EpKO or Creb1 MesKO lungs (Fig. 4a) . However, Crem mRNA levels increased in Creb1
EpKO lungs (1.4 fold, p < 0.05), and a greater increase was observed in Creb1 MesKO lungs (2.7 fold, p < 0.001) (Fig. 4a) . Despite this, immunohistochemical analysis using either an N-terminal or a C-terminal Crem antibody found no detectable levels of Crem protein in either control, Creb1
MesKO or Creb1 EpKO fetal lungs at E18.5 ( Supplementary Fig. S5 ). Furthermore, we could not detect Crem protein in the embryonic lung at any developmental stage examined (E13.5, E15.5, PN6.5, Adult) ( Supplementary Fig. S5 ). Normal Crem immunoreactivity (from both N-and C-terminal antibodies) however, was seen in round spermatid cell nuclei of the adult mouse testis, consistent with known sites of Crem expression 6 ( Supplementary Fig. S5 ). (Fig. 4b,c) , and immunohistochemical analysis of Creb1 MesKO ; Crem −/− lungs did not exhibit any defect in epithelial differentiation (Supplementary Fig. S6 ). Interestingly however, numbers of Creb1
MesKO ; Crem +/− and Creb1
MesKO
; Crem −/− mice at 2 weeks was significantly lower than the expected 25% Mendelian frequency (Table 3) . Creb1
MesKO ; Crem −/− mice were never found, although due to extremely low progeny numbers and a high rate of maternal cannibalization there was insufficient statistical power to determine a causal link from this genotype to loss of survival (Supplementary Table S3 
Glucocorticoid hormone synthesis is unaffected in in Creb1
fl−/− mice. As we had not observed any respiratory phenotype in Creb1 EpKO or Creb1 MesKO mice, we re-examined Creb1 fl−/− fetal mice and tested for disruption of the GC signaling pathway, which is required for late stage lung maturation via the GC Receptor (GR, Nr3c1) 22 . We examined relative adrenal gland proportions, plasma corticosterone levels as well as pulmonary GR expression in E18.5 control and Creb1 fl−/− fetal mice. However, transverse sections through lumbar vertebrae showed that adrenal glands in Creb1 fl−/− fetal mice appeared similar to controls (Fig. 5a,b) . Corticosterone levels were slightly increased in Creb1 fl−/− fetal mice, though this did not reach statistical significance (Fig. 5e) . Lastly, the level of GR immunoreactivity in Creb1 fl−/− fetal lungs was comparable to controls, and appeared to be localized primarily to the nucleus indicative of normal GC ligand-bound GR activation (Fig. 5c,d) . Together, these results suggest that the respiratory phenotype in Creb1 fl−/− fetal mice is not caused by loss of GC signaling.
Diaphragm and intercostal musculature development are unaffected in Creb1 fl−/− mice. We also re-examined Creb1 fl−/− fetal mice for defects in muscular elements known to be important for late stage lung development such as the diaphragm and intercostal muscle. We firstly inspected E18.5 Creb1 fl−/− fetal mice for possible diaphragm herniation, however careful examination of the thoracic cavity (in 3 separate knockout animals) did not reveal any noticeable defects in diaphragm muscle tissue. Secondly, we tested whether FBM-associated muscle fibres were properly formed in Creb1 fl−/− fetal mice at E18.5 using immunohistochemistry for the mature muscle marker myosin heavy chain (MyHC). In transverse sections through thoracic vertebrae, we noticed no difference in MyHC-positive diaphragm or skeletal intercostal muscle fibres in Creb1 fl−/− mice compared with controls ( Fig. 6a-f) . Another Creb1-regulated structural muscle protein, desmin 23 , similarly appeared at normal levels in all skeletal and diaphragm musculature examined in E18.5 Creb1 fl−/− fetal mice (Fig. 6g,h ). In addition, CD31 immunohistochemistry showed that these muscular elements were properly vascularized (Fig. 6i-l ). Lastly, we tested for evidence of lung hypoplasia in E18.5 Creb1 fl−/− mice via analysis of lung wet weight/body weight ratios (Fig. 6m) . No difference was detected between Creb1 fl−/− (3.8 ± 0.2%, n = 3) and Creb1 fl+/− littermate controls (3.4 ± 0.1%, n = 3). Thus, it is unlikely that the respiratory phenotype in Creb1 fl−/− mice is due to loss of in utero FBM-associated muscular activity. Table 3 . Analysis of survival at two weeks of age in Creb1
MesKO
; Crem +/− mice. The genotype of the progeny was determined as described in Materials and Methods at two weeks of age. The expected number of each genotype is indicated in brackets, and was calculated according to a predicted Mendelian allele inheritance ratio. Statistically significant deviations from the expected frequency was determined using a goodness-of-fit test with significance set a p < 0.05. 
Discussion
In this study we initially show that conditional Creb1 deletion in the respiratory epithelium, endothelium or mesenchyme surprisingly has no major impact on lung sacculation, suggesting that lung-localized Creb1 has no essential role in mammalian lung development. While Creb1 is widely expressed in the developing lung, the primary site of Creb1 transcriptional function is believed to be the distal epithelium, based on the expression of Ser133 pCreb1 in the pseudoglandular phase 10, 13 . Our Creb1 immunohistochemistry in Creb1 EpKO mice showed that a subset of epithelial cells, primarily from proximal regions, often escaped deletion. It is therefore possible that sufficient Creb1 activity allowed normal lung development to proceed in Creb1 EpKO mice. While it is expected that a small subset of proximal epithelial cells will not undergo Creb1 deletion due to lack of SPCrtTA transgene activation (such as the neuroepithelial lineage 24 ), it is also conceivable that the Creb fl locus is somewhat resistant to Cre-mediated recombination. This latter possibility appears more likely given that we observe no expansion of neuroepithelial (or other) proximal epithelial lineages in Creb1
EpKO lungs. Nevertheless, our finding of largely complete Creb1 deletion in the distal epithelium of Creb1
EpKO lungs argue against a normal phenotype in these mice resulting from residual epithelial Creb1 signaling. On the other hand, strong Ser133 pCreb1 expression in mesenchymal cells during the saccular phase also argues for a role for Creb1 in the mesenchyme 10 , yet while Dermo1 Cre -mediated deletion appeared mostly complete in Creb1
MesKO lungs, we also did not observe any respiratory phenotype in these mice. Interestingly, mice with a Ser133 to Alanine residue mutation (Creb1 Ser133A) in the Creb1 gene are viable and healthy, albeit born at a reduced Mendelian frequency when bred on a C57BL/6J background 25 . This suggests that distal epithelial Ser133 pCreb1 expression is not an indicator of important Creb1 activity in the lung, and/or that a partial functional redundancy exists between other phosphorylation sites for Creb1 transcriptional activation and normal embryonic development. It would be valuable to generate mice with compound Creb1 phosphorylation site mutations to pursue this hypothesis. In addition, it would be worthwhile to generate compound lung epithelial/mesenchymal Creb1 mouse mutants to investigate the potential combined requirement of Creb1 in these germ layers for normal lung development.
We next investigated several alternate mechanisms in order to explain the severe lung phenotype observed in total Creb1 mouse mutants. Firstly, we provide evidence that the lack of a respiratory phenotype in conditional Creb1 deletions is not caused by compensatory activities of Crem or Atf1. This functional redundancy within the Creb/Atf1 subfamily is believed to occur via up-regulation of these factors' expression in the absence of Creb1 8, 26, 27 . Our investigation shows that while upregulation of Crem, and not Atf1, gene expression takes place in both E18.5 Creb1
EpKO and Creb1 MesKO fetal lungs, the lack of Crem immunoreactivity in both controls and conditional knockout lungs indicates that Crem protein is neither synthesized in the wildtype fetal lung, nor upregulated to detectable levels in the absence of Creb1. Although we did not test all Crem isoforms in our qPCR and immunohistochemcial analyses, more compelling is our finding that lungs of Creb1
MesKO mice, which showed a higher upregulation of Crem than Creb1
EpKO lungs, displayed no lung phenotype even when bred on a Crem deficient genetic background. It is therefore possible that in most tissues, Crem mRNA upregulation in the absence of Creb1 has little or no functional outcome, with the exception of perhaps the brain where Crem compensation protects against neuronal cell death 11 . Interestingly however, our finding of reduced neonatal survival in Creb1
MesKO ; Crem +/− and Creb1 MesKO ; Crem −/− mice point to a compensatory role for Crem in Creb1-deficient mesodermal tissues during early postnatal life. This phenotype would be interesting to investigate, however given the wide range of non-respiratory organs also targeted by the Dermo1
Cre allele including bone 16 , kidney 28 and heart 29 , isolating the affected system(s) may be a challenging task. Tracing the origin of respiratory defects in mouse mutants can be difficult given that a loss of gene function in a separate tissue can potentially impair lung development via an indirect (or non-autonomous) mechanism. For example, mice lacking the myogenic factor Myogenin (Myog) exhibit defective lung sacculation due to poorly developed diaphragm muscle 30 , though Myog is not expressed in the lung. Similarly, loss of the skeletal muscle-specific factor Myf5, also not expressed in the lung, prevents normal lung sacculation 31 . More difficult to interpret are lung phenotypes from total mouse mutants in which the deleted gene is expressed in multiple tissues including lung, yet other musculoskeletal defects are also present which may contribute or represent the sole cause of the lung phenotype. For example, the insulin-like growth factor-1 (Igf1r) is widely expressed during embryonic development, and Igf1r total knockout mice exhibit both fetal lung and diaphragmatic defects 32 . Advantageously, the multiple systems targeted by the Dermo1
Cre allele also help to explore whether certain non-respiratory mechanisms potentially underpin the Creb1 −/− lung phenotype. For example, it could be argued that impaired development of the ribcage or vertebrae may prevent normal expansion of the underlying lung or provide inadequate structural support to respiratory muscles, thus arresting lung development prior to sacculation 33 . This suggestion has significant merit given the vertebral fusions occasionally observed in Creb1 −/− mice 34 but is also supported by previous findings in mice which utilize tissue-specific overexpression of a dominant negative Creb1 transgene known as A-CREB, which specifically blocks DNA binding of the Creb/Atf1 subfamily 35 . A-CREB overexpression in chondrocytes results in a reduced rib-cage circumference and neonatal lethality 36 , while mice overexpressing A-CREB in the mesoderm also die at birth, presumably due to respiratory failure and exhibit profound ribcage, as well as other skeletal defects 34 . Conversely, we did not observe any lung or skeletal phenotype in Creb1
MesKO or Creb1
MesKO
; Crem −/− fetal mice, although a lack of Creb1 expression in ribcage chondrocytes due to Dermo1 Cre -mediated deletion was apparent in these mutants. We speculate that these discrepancies are partially due to differences in promoter-specific Dermo1
Cre versus A-CREB expression in mesodermal cell lineages, although it is also conceivable that Atf1 can compensate for lack of Creb1/Crem for correct skeletal development. Another possibility is that the lack of CRE occupancy in A-CREB mutants leads to aberrant promoter binding by other factors which may produce off-target developmental outcomes via abnormal target gene regulation. We therefore suggest a level of caution when interpreting the phenotype in A-CREB mouse mutants.
We also investigated, but excluded, the possibility that the Creb1 −/− lung phenotype is secondary to muscular defects. Late stage lung development is known to be critically dependent on mechanical influences from in utero 'fetal breathing movements' (FBMs), which are driven by contractile activities of the diaphragm and skeletal intercostal musculature. Absence of skeletal muscles results in lung hypoplasia during late in utero development as seen in compound knockout mice which lack both of the myotomal factors Myf5 and MyoD 37 . Abnormalities in diaphragm development can similarly cause lung hypoplasia, most commonly due to diaphragmatic herniation whereby abdominal contents invade the thoracic space and prevent fetal lung expansion 38 . Intriguingly, a previous study using Creb1 −/− mice found PKA-Creb1 signaling to be required for important myotomal factors including Pax3, MyoD and Myf5 during early development 39 . However, our MyHC immunohistochemistry show that Creb1 fl−/− mice do not exhibit any defects in FBM-associated musculature that would be consistent with a loss of saccular lung development. Furthermore, previous and current findings from our group have not found any evidence of lung hypoplasia in Creb1 fl−/− mice, which would be expected in the event of impaired FBM-associated musculature. For example, in our current study the lung wet weight/body weight ratios in Creb1 fl−/− fetal mice were comparable to controls, though this is normally reduced in lung hypoplasia. Additionally, our previous work in E18.5 Creb1 fl−/− lungs showed no significant difference in cell apoptosis and a slightly higher rate of cell proliferation 10 , though these are normally increased and reduced, respectively, in lung hypoplasia. Another potential mechanism explored was the possibility that global loss of Creb1 disrupts components of the GC-GR signaling pathway, which is required for late stage lung maturation. On one hand, insufficient levels Scientific RepoRts | 6:25569 | DOI: 10.1038/srep25569 of corticosterone (the active rodent GC ligand) prevent GR transcriptional signaling as seen in corticotrophin releasing hormone (Crh) knockout mice 40 . On the other hand, GR mouse mutants exhibit elevated corticosterone levels secondary to marked adrenal hypertrophy 22 . Interestingly, Creb1 has a recognized role in promoting gene expression of Crh 41 , supporting a role for Creb1 in GC production. However, free corticosterone levels appeared relatively unchanged in Creb1 fl−/− mice, consistent with normally-sized adrenal glands. In addition, our finding of nuclear GR localization in Creb1 fl−/− lungs implies that sufficient GC ligand is available to promote cytoplasmic to nuclear GR translocation. The normal levels of corticosterone in Creb1 fl−/− mice are perhaps unsurprising given that a fetal loss of GCs in various GC signaling deficient mouse mutants can be compensated for by a maternal transfer of corticosterone across the placenta 42 . Therefore, while our results do not preclude an absence of Crh expression in Creb1 fl−/− mice, this is unlikely to be the cause of the Creb1 fl−/− respiratory phenotype. Normal GR expression in Creb1 fl−/− lungs also suggests Creb1 is not required for lung GR expression. In summary, we find that the requirement of Creb1 for normal mammalian lung development is not dependent upon its expression in the respiratory epithelium or mesenchyme. Furthermore, we show that this requirement is not indirectly due to known or suspected Creb1 involvement in musculoskeletal development, nor the GC signaling pathway. Therefore, the underlying cause behind the respiratory phenotype in total Creb1 mouse mutants remains unknown. One further possibility not explored in this study is whether the recognized involvement of Creb1 in the peripheral nervous system 43 indirectly stimulates lung sacculation via innervation of FBM-associated muscles. However, while innervation of muscular elements such as the diaphragm is known to be required for lung function at birth 44 , it is uncertain whether it is also essential for the saccular process of lung development. Conditional Creb1 deletion in a wider range of neuronal cell lineages would therefore prove a valuable exercise to address this potential cause of the lung phenotype observed in Creb1 fl−/− mice.
Methods
Mouse models. Histology, Immunohistochemistry and Lung Tissue morphometry. Whole fetal mouse torsos were immersion-fixed in 4% paraformaldehyde (PFA) overnight at 4 °C with agitation then embedded in paraffin. 5μ m sections were cut and mounted on slides, then used for histological or immunostaining analyses according to a standard protocol as previously described 10 . Lung tissue morphometry was performed according to previously published methods 45 . Primary antibodies used are shown in Supplementary Table S2. RNA Extraction, cDNA synthesis and quantitative PCR. Total RNA and cDNA was obtained from fetal lungs using TRIzol reagent (Invitrogen, Carlsbad, CA) and M-MLV Reverse Transcriptase (Promega, Madison WI), respectively, as per the manufacturer's instructions. The integrity of 28S and 18S rRNA from total RNA was always assessed on agarose gels prior to further analysis. qPCR analysis was performed in triplicate for each biological replicate using at least two housekeeping genes per analysis: 18S rRNA and Rps29. Other qPCR primers were designed to include at least one oligo overlapping an exon-exon boundary, using the web-based software Primer3 46 . Primer efficiency was then calculated using a standard curve and fetal lung cDNA template. Sequences for these primers can be found in a previous publication 10 . Cycling was performed on a CFX384
Touch ™ Real-Time PCR Detection System (Bio-Rad, Richmond, CA). Relative differential expression was then determined using CFX Manager ™ software (Bio-Rad).
Corticosterone measurement. Trunk blood (5-10 μ l) was obtained from fetal wildtype and Creb1 fl−/− mice and assayed for free corticosterone levels using a Corticosterone Double Antibody RIA Kit (MP Biomedicals, Solon, OH), as per the manufacturer's instructions. Radioactivity was measured using a 1470 Perkin Elmer automated gamma counter (Perkin Elmer, Waltham, MA).
Statistical Analysis. GraphPad Prism software was used to analyze the results of all experiments with a statistical significance set at p < 0.05. Statistically significant deviations in neonatal mouse survival at two weeks of age was calculated using a goodness-of-fit test.
